What is the current Price Target for the Polypid Ltd stock?

The average Polypid Ltd target price is $11.40. This is 290.41% higher than the current stock price. The highest price target is 345.21%, the lowest is 242.47%. 5 Analysts have issued a price target Polypid Ltd 2026 .

How high will the Polypid Ltd stock rise?

No reliable answer can be given as to how high the Polypid Ltd stock will rise. The performance of stocks, including the Polypid Ltd stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Polypid Ltd stock today?

The performance of Polypid Ltd stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Polypid Ltd stock fall?

The decline in Polypid Ltd stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Polypid Ltd Forecast, price target & analysts

$3.00

2.90% today

Nasdaq, Feb 28, 08:14 pm CET

ISIN

IL0011326795

Symbol

PYPD

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Polypid Ltd Target price 2025 - Analyst rating & recommendation

Polypid Ltd Classifications & Recommendation:

Buy

80%

Hold

20%

Polypid Ltd Price Target

Target Price	$11.40
Price	$2.92
Potential	290.41% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Polypid Ltd 2026 . The average Polypid Ltd target price is $11.40. This is 290.41% register free of charge higher than the current stock price. The highest price target is $13.00 345.21% register free of charge , the lowest is $10.00 242.47% register free of charge .
	A rating was issued by 5 analysts: 4 Analysts recommend Polypid Ltd to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Polypid Ltd stock has an average upside potential 2026 of 290.41% register free of charge . Most analysts recommend the Polypid Ltd stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-4.91	-2.53
	71.10%	48.47%
P/E		negative

2 Analysts have issued a Polypid Ltd forecast for earnings per share. The average Polypid Ltd <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-4.91	71.10%
2025	$-2.53 48.47% Unlock
2026	$-1.49 41.11% Unlock
2027	$0.06 104.03% Unlock
2028	$1.17 1,850.00% Unlock
2029	$2.17 85.47% Unlock

Current	-0.59	20.27%
2025	-1.15 94.92% Unlock
2026	-1.96 70.43% Unlock
2027	48.67 2,583.16% Unlock
2028	2.50 94.86% Unlock
2029	1.35 46.00% Unlock

Polypid Ltd...

Current Polypid Ltd Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 26 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 16 2024
Craig-Hallum	Locked ➜ Locked	Locked	Nov 04 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 02 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 26 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 16 2024
Locked Craig-Hallum: Locked ➜ Locked	Nov 04 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 02 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now